Details for New Drug Application (NDA): 203759
✉ Email this page to a colleague
The generic ingredient in RITONAVIR is ritonavir. There are twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ritonavir profile page.
Summary for 203759
Tradename: | RITONAVIR |
Applicant: | Cipla |
Ingredient: | ritonavir |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 203759
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | May 10, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription